FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41494111000001104: Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2888221000001118 Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2888241000001111 Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has AMP Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Is a Letrozole 2.5mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has specific active ingredient Letrozole true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Letrozole 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start